ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$582M |
| 2 |
Robinhood
HOOD
|
+$430M |
| 3 |
Roku
ROKU
|
+$350M |
| 4 |
Teladoc Health
TDOC
|
+$294M |
| 5 |
Twilio
TWLO
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.04B |
| 2 |
Zillow
Z
|
+$739M |
| 3 |
Unity
U
|
+$634M |
| 4 |
Coinbase
COIN
|
+$448M |
| 5 |
Shopify
SHOP
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.6% |
| 2 | Technology | 31.26% |
| 3 | Communication Services | 12.83% |
| 4 | Consumer Discretionary | 9.99% |
| 5 | Financials | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Similarweb
SMWB
$658M
| $2.74M | 0.01% |
152,868
-2,844
| -2% | -$52.2K |
|
177
CollPlant Biotechnologies
CLGN
$6.41M
| $2.71M | 0.01% |
165,454
-25,836
| -14% | -$461K |
|
|
NTBL
178
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $2.62M | 0.01% |
38,006
-1,807
| -5% | -$139K |
|
|
PPBT
179
Purple Biotech
PPBT
$2.33M
| $2.58M | 0.01% |
3,312
-368
| -10% | -$313K |
|
180
InMode
INMD
$880M
| $2.57M | 0.01% |
36,457
-101,743
| -74% | -$8.16M |
|
181
JFrog
FROG
$10.8B
| $2.54M | 0.01% |
85,514
+4,439
| +5% | +$146K |
|
182
Gilat Satellite Networks
GILT
$848M
| $2.53M | 0.01% |
358,058
-26,217
| -7% | -$205K |
|
|
WKME
183
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $2.48M | 0.01% |
126,192
+7,856
| +7% | +$176K |
|
|
TARO
184
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $2.47M | 0.01% |
49,259
-1,908
| -4% | -$107K |
|
185
WIX.com
WIX
$2.52B
| $2.47M | 0.01% |
15,633
+3,259
| +26% | +$565K |
|
186
Allot
ALLT
$383M
| $2.45M | 0.01% |
206,051
+11,286
| +6% | +$148K |
|
187
Teva Pharmaceuticals
TEVA
$41.2B
| $2.44M | 0.01% |
304,792
-99,204
| -25% | -$895K |
|
188
PolyPid
PYPD
$92.8M
| $2.33M | 0.01% |
13,552
-2,162
| -14% | -$456K |
|
189
Ceragon Networks
CRNT
$201M
| $2.33M | 0.01% |
904,394
-124,418
| -12% | -$375K |
|
190
Cognyte Software
CGNT
$680M
| $2.23M | 0.01% |
142,013
-2,079
| -1% | -$42K |
|
|
MBAI
191
Check-Cap
MBAI
$10.9M
| $2.2M | 0.01% |
162,889
+10,363
| +7% | +$174K |
|
192
Enlivex Ltd
ENLV
$35M
| $2.18M | 0.01% |
23,287
-7,233
| -24% | -$852K |
|
|
BLRX
193
BioLineRX
BLRX
$11.8M
| $2.16M | 0.01% |
26,493
-355
| -1% | -$37K |
|
194
Fiverr
FVRR
$339M
| $2.02M | 0.01% |
17,784
+896
| +5% | +$140K |
|
195
MediWound
MDWD
$185M
| $1.97M | 0.01% |
119,167
+9,899
| +9% | +$206K |
|
196
Entera Bio
ENTX
$141M
| $1.95M | 0.01% |
690,922
+7,915
| +1% | +$29.7K |
|
|
GMDA
197
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $1.91M | 0.01% |
751,069
+127,395
| +20% | +$420K |
|
198
Nano X Imaging
NNOX
$73.8M
| $1.89M | 0.01% |
129,903
+6,290
| +5% | +$130K |
|
199
Playtika
PLTK
$1.12B
| $1.87M | 0.01% |
108,001
-47,505
| -31% | -$1.06M |
|
|
CMMB
200
Chemomab Therapeutics
CMMB
$14.1M
| $1.84M | 0.01% |
66,823
+21,692
| +48% | +$770K |
|
Similar funds
ARK Investment Management's Q4 2021 Portfolio in Review
As of Q4 2021, ARK Investment Management held 374 positions worth $33.1B, down 21% from $41.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
ARK Investment Management withdrew a net $3.12B in Q4 2021, closing 12 positions and reducing 191 holdings. Its most notable exit was GeneDx Holdings, an estimated $71.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.
Against the trend, ARK Investment Management opened a new position in Nu Holdings worth $36.8M.
- ARK Investment Management's largest Q4 2021 buy was Nu Holdings: 3,928,467 shares worth $36.8M.
- ARK Investment Management added most to Zoom in Q4 2021, an estimated $582M increase.
- ARK Investment Management's biggest Q4 2021 reduction was Tesla, cutting an estimated $2.04B.
- ARK Investment Management fully exited GeneDx Holdings in Q4 2021, selling an estimated $71.3M.
- ARK Investment Management's ten largest holdings make up 40% of its $33.1B portfolio in Q4 2021.
- ARK Investment Management opened 75 new positions and closed 12 in Q4 2021.
- ARK Investment Management's portfolio value fell 21% quarter-over-quarter to $33.1B.
Based on ARK Investment Management's 13F filing for Q4 2021, filed 28 Jan 2022.